Bureau Veritas SA - BVI.PA

BVI.PA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
BVI.PA	0.3	4.9	3.6	2.7	4.9	21.8	20.1	22.0	63.4	41472.4
S&P 500	-0.5	1.2	2.9	5.4	10.9	23.1	32.9	85.9	198.9	34104.6

Compare BVI.PA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	BVI.PA
name	Bureau Veritas SA
price	30.14
changes percentage	0.2661
change	0.08
day low	29.98
day high	30.28
year high	31.54
year low	24.46
market cap	13482277093
price avg 50	29.448
price avg 200	28.5882
exchange	EURONEXT
volume	1274938
avg volume	989580
open	30.1
previous close	30.06
eps	1.1
pe	27.4
earnings announcement	2025-02-25T07:30:00.000+0000
shares outstanding	447321735
timestamp	2025-01-31 16:38:26

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 71.7%

Overall Quarterly Financial Health: 38.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	5867800000	5650600000	3.84
gross profit	1756200000	1274500000	37.80
gross profit ratio	0.3	0.23	32.69
research and development expenses	5200000	4900000	6.12
operating expenses	931100000	492600000	89.02
interest income	45000000	12500000	260.00
interest expense	111600000	95100000	17.35
ebitda	1159000000	1110100000	4.41
ebitdaratio	0.2	0.19	3.44
operating income	824400000	781900000	5.44
operating income ratio	0.14	0.14	1.53
net income	503700000	466700000	7.93
net income ratio	0.09	0.08	3.93
eps	1.11	1.03	7.77

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 5,868 million in 2023 from 5,651 million in 2022 representing a change of 3.84%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,756 million in 2023 from 1,274 million in 2022 representing a change of 37.8%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 5 million in 2023 from 5 million in 2022 representing a change of 6.12%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,159 million in 2023 from 1,110 million in 2022 representing a change of 4.41%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 824 million in 2023 from 782 million in 2022 representing a change of 5.44%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 504 million in 2023 from 467 million in 2022 representing a change of 7.93%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.11 in 2023 from 1.11 in 2022 representing a change of 7.77%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 931 million in 2023 from 493 million in 2022 representing a change of 89.02%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	3116600000	2963600000	5.16
gross profit	605500000	709000000	-14.60
gross profit ratio	0.19	0.24	-18.79
research and development expenses	0	5200000	-100.00
operating expenses	217200000	263500000	-17.57
interest income	22600000	22600000	0.00
interest expense	42400000	69700000	-39.17
ebitda	541300000	598300000	-9.53
ebitdaratio	0.17	0.2	-14.44
operating income	388300000	445500000	-12.84
operating income ratio	0.12	0.15	-17.12
net income	234300000	271200000	-13.61
net income ratio	0.08	0.09	-17.85
eps	0.52	0.6	-13.33

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3,117 million in 2024Q2 from 2,964 million in 2023Q4 representing a change of 5.16%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 217 million in 2024Q2 from 264 million in 2023Q4 representing a change of -17.57%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 606 million in 2024Q2 from 709 million in 2023Q4 representing a change of -14.6%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 5 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 541 million in 2024Q2 from 598 million in 2023Q4 representing a change of -9.53%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 388 million in 2024Q2 from 446 million in 2023Q4 representing a change of -12.84%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 234 million in 2024Q2 from 271 million in 2023Q4 representing a change of -13.61%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.52 in 2024Q2 from 0.52 in 2023Q4 representing a change of -13.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	6644400000	7119200000	-6.67
total liabilities	4650600000	5191200000	-10.41
total equity	1993800000	1928000000	3.41
cash and cash equivalents	1173900000	1663200000	-29.42
short term investments	1200000	21000000	-94.29
long term investments	108900000	108100000	0.74
total current assets	3131000000	3673500000	-14.77
total non current assets	3513400000	3445700000	1.96
total current liabilities	1873100000	2389800000	-21.62
total non current liabilities	2777500000	2801399999	-0.85
common stock	54500000	54300000	0.37
retained earnings	1881600000	1807800000	4.08
total debt	2538100000	3045200000	-16.65

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 6,644 million in 2023 from 7,119 million in 2022 representing a change of -6.67%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,174 million in 2023 from 1,663 million in 2022 representing a change of -29.42%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 1 million in 2023 from 21 million in 2022 representing a change of -94.29%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 3,131 million in 2023 from 3,674 million in 2022 representing a change of -14.77%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 4,651 million in 2023 from 5,191 million in 2022 representing a change of -10.41%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1,994 million in 2023 from 1,928 million in 2022 representing a change of 3.41%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 1,873 million in 2023 from 2,390 million in 2022 representing a change of -21.62%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 54 in 2023 from 54 in 2022 representing a change of 0.37%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 1,882 million in 2023 from 1,808 million in 2022 representing a change of 4.08%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2,538 million in 2023 from 3,045 million in 2022 representing a change of -16.65%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	7201600000	6644400000	8.39
total liabilities	5503800000	4650600000	18.35
total equity	1697800000	1993800000	-14.85
cash and cash equivalents	1522400000	1173900000	29.69
short term investments	7100000	9100000	-21.98
long term investments	99300000	108900000	-8.82
total current assets	3599700000	3131000000	14.97
total non current assets	3563900000	3513399999	1.44
total current liabilities	2702500000	1873100000	44.28
total non current liabilities	2801300000	2777500000	0.86
common stock	54600000	54500000	0.18
retained earnings	1575400000	1881600000	-16.27
total debt	3045900000	2538100000	20.01

Overall Score of Quarterly Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 7,202 million in 2024Q2 from 6,644 million in 2023Q4 representing a change of 8.39%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,522 million in 2024Q2 from 1,174 million in 2023Q4 representing a change of 29.69%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 3,600 million in 2024Q2 from 3,131 million in 2023Q4 representing a change of 14.97%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 55 in 2024Q2 from 54 in 2023Q4 representing a change of 0.18%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 5,504 million in 2024Q2 from 4,651 million in 2023Q4 representing a change of 18.35%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 1,698 million in 2024Q2 from 1,994 million in 2023Q4 representing a change of -14.85%. This indicates a decrease in shareholders' equity.

  Short Term Investments: Short Term Investments decreased to 7 million in 2024Q2 from 9 million in 2023Q4 representing a change of -21.98%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 2,702 million in 2024Q2 from 1,873 million in 2023Q4 representing a change of 44.28%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 1,575 million in 2024Q2 from 1,882 million in 2023Q4 representing a change of -16.27%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 3,046 million in 2024Q2 from 2,538 million in 2023Q4 representing a change of 20.01%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-485600000	240000000	-302.33
operating cash flow	819700000	782500000	4.75
free cash flow	662100000	652400000	1.49
capital expenditure	-157600000	-130100000	-21.14
depreciation and amortization	291500000	297100000	-1.88
deferred income tax	0	-640900000	100.00
stock based compensation	0	27200000	-100.00
accounts payables	-5200000	33000000	-115.76
inventory	0	0	NaN
acquisitions net	-41400000	-73100000	43.37
investments in property plant and equipment	-157600000	-130100000	-21.14
net cash used for investing activites	-188000000	-200000000	6.00
debt repayment	-641400000	-20100000	-3091.04
common stock issued	5700000	8600000	-33.72
common stock repurchased	-1900000	-49800000	96.18
dividends paid	-396300000	-280900000	-41.08
net cash used provided by financing activities	-1080600000	-359500000	-200.58
cash at end of period	1170100000	1663200000	-29.65
accounts receivables	-130500000	-52500000	-148.57
cash at beginning of period	1655700000	1423200000	16.34

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -486 million in 2023 from 240 million in 2022 representing a change of -302.33%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -641 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Dividends Paid: Dividends Paid decreased to -396 million in 2023 from -281 million in 2022 representing a change of -41.08%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 820 million in 2023 from 782 million in 2022 representing a change of 4.75%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 662 million in 2023 from 652 million in 2022 representing a change of 1.49%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -158 million in 2023 from -130 million in 2022 representing a change of -21.14%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 27 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 5 million in 2023 from 33 million in 2022 representing a change of -115.76%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -130 million in 2023 from -52 million in 2022 representing a change of -148.57%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	262399999	594300000	-55.85
free cash flow	200799999	516500000	-61.12
capital expenditure	-61600000	-77800000	20.82
depreciation and amortization	126000000	156100000	-19.28
deferred income tax	0	0	NaN
stock based compensation	12100000	13000000	-6.92
accounts receivables	-112600000	-33000000	-241.21
accounts payables	20600000	11400000	80.70
inventory	0	0	NaN
acquisitions net	-70000000	-16700000	-319.16
investments in property plant and equipment	-61600000	-77800000	20.82
net cash used for investing activites	-130199999	-99300000	-31.12
debt repayment	424900001	-499400000	185.08
common stock issued	0	0	NaN
common stock repurchased	-199200000	-800000	-24800.00
dividends paid	-9100000	-383000000	97.62
net cash used provided by financing activities	209600000	-987800000	121.22
net change in cash	1518100000	-512700000	396.10
cash at end of period	1518100000	1175000000	29.20
cash at beginning of period	0	1687700000	-100.00

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,518 million in 2024Q2 from -513 million in 2023Q4 representing a change of 396.1%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation decreased to 12 million in 2024Q2 from 13 million in 2023Q4 representing a change of -6.92%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -113 million in 2024Q2 from -33 million in 2023Q4 representing a change of -241.21%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -9 million in 2024Q2 from -383 million in 2023Q4 representing a change of 97.62%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 262 million in 2024Q2 from 594 million in 2023Q4 representing a change of -55.85%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 201 million in 2024Q2 from 516 million in 2023Q4 representing a change of -61.12%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -62 million in 2024Q2 from -78 million in 2023Q4 representing a change of 20.82%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 21 million in 2024Q2 from 11 million in 2023Q4 representing a change of 80.7%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q2 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	12.95	12.5	3.64
net income per share	1.11	1.03	7.72
operating cash flow per share	1.81	1.73	4.55
free cash flow per share	1.46	1.44	1.29
cash per share	2.59	3.72	-30.36
book value per share	4.4	4.26	3.21
tangible book value per share	-1.09	-6.09	82.10
shareholders equity per share	4.27	4.12	3.77
interest debt per share	5.85	6.95	-15.78
market cap	10360332387.88	11127173964.28	-6.89
enterprise value	11724532387.88	12509173964.28	-6.27
pe ratio	20.57	23.84	-13.73
price to sales ratio	1.77	1.97	-10.34
pocfratio	12.64	14.22	-11.12
pfcf ratio	15.65	17.06	-8.26
pb ratio	5.35	5.98	-10.45
ptb ratio	5.35	5.98	-10.45
ev to sales	2.0	2.21	-9.74
enterprise value over ebitda	10.12	11.27	-10.23
ev to operating cash flow	14.3	15.99	-10.53
ev to free cash flow	17.71	19.17	-7.65
earnings yield	0.05	0.04	15.92
free cash flow yield	0.06	0.06	9.00
debt to equity	1.31	1.64	-19.84
debt to assets	0.38	0.43	-10.70
net debt to ebitda	1.18	1.24	-5.45
current ratio	1.67	1.54	8.74
interest coverage	7.39	8.22	-10.15
income quality	1.63	1.68	-2.94
dividend yield	0.04	0.03	51.52
payout ratio	0.79	0.6	30.72
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.0	0.0	2.19
intangibles to total assets	0.37	0.66	-43.05
capex to operating cash flow	0.19	0.17	15.64
capex to revenue	0.03	0.02	16.65
capex to depreciation	0.54	0.44	23.46
stock based compensation to revenue	0	0.0	-100.00
graham number	10.34	9.78	5.73
roic	0.11	0.1	16.38
return on tangible assets	0.12	0.19	-36.67
graham net net	-4.9	-5.09	3.75
working capital	1257900000	1283700000	-2.01
tangible asset value	-493600000	-2751900000	82.06
net current asset value	-1519600000	-1517700000	-0.13
invested capital	4525800000	6719700000	-32.65
average receivables	1604050000	1533250000	4.62
average payables	539100000	544949999.5	-1.07
average inventory	52000000	56150000	-7.39
days sales outstanding	101.99	101.32	0.66
days payables outstanding	46.22	46.51	-0.63
days of inventory on hand	4.38	4.56	-4.07
receivables turnover	3.58	3.6	-0.66
payables turnover	7.9	7.85	0.63
inventory turnover	83.4	80.0	4.25
roe	0.26	0.25	3.80
capex per share	0.35	0.29	20.91

• Positive

  ROE: Return on Equity (ROE) increased to 0.26 on 2023-12-31 from 0.25 on 2022-12-31, representing a change of 3.80%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.67 on 2023-12-31 from 1.54 on 2022-12-31, representing a change of 8.74%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 20.57 on 2023-12-31 from 23.84 on 2022-12-31, representing a change of -13.73%. Indicating a decrease in the relative valuation of the company's stock.

• Debt-to-Equity Ratio:

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
BVI.PA
calendar year	2024	2023	NaN
revenue per share	6.9	6.53	5.62
net income per share	0.52	0.6	-13.23
operating cash flow per share	0.58	1.31	-55.66
free cash flow per share	0.44	1.14	-60.96
cash per share	3.39	2.61	29.85
book value per share	3.76	4.4	-14.48
tangible book value per share	-1.88	-1.09	-73.05
shareholders equity per share	3.61	4.27	-15.45
interest debt per share	6.84	5.75	18.94
market cap	11924378400	10374537196.45	14.94
enterprise value	13447878400	11738737196.45	14.56
pe ratio	12.72	9.56	33.04
price to sales ratio	3.83	3.5	9.30
pocfratio	45.44	17.46	160.32
pfcf ratio	59.38	20.09	195.65
pb ratio	7.32	5.36	36.52
ptb ratio	7.32	5.36	36.52
ev to sales	4.31	3.96	8.94
enterprise value over ebitda	24.84	19.62	26.62
ev to operating cash flow	51.25	19.75	159.46
ev to free cash flow	66.97	22.73	194.67
earnings yield	0.02	0.03	-24.84
free cash flow yield	0.02	0.05	-66.18
debt to equity	1.87	1.31	42.54
debt to assets	0.42	0.38	10.72
net debt to ebitda	2.81	2.28	23.44
current ratio	1.33	1.67	-20.31
interest coverage	9.16	6.39	43.28
income quality	1.12	2.19	-48.89
dividend yield	0.0	0.04	-97.93
payout ratio	0.04	1.41	-97.25
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.35	0.37	-5.48
capex to operating cash flow	0.23	0.13	79.33
capex to revenue	0.02	0.03	-24.71
capex to depreciation	0.49	0.5	-1.91
stock based compensation to revenue	0.0	0.0	-11.49
graham number	6.49	7.58	-14.35
roic	0.05	0.06	-16.10
return on tangible assets	0.05	0.07	-22.82
graham net net	-5.37	-7.59	29.29
working capital	897200000	1257900000	-28.67
tangible asset value	-850500000	-493600000	-72.31
net current asset value	-1904100000	-1519600000	-25.30
invested capital	4235900000	4525800000	-6.41
average receivables	1033450000	992100000	4.17
average payables	849700000	838300000	1.36
average inventory	24650000	24650000.5	-0.00
days sales outstanding	59.69	0	NaN
days payables outstanding	42.25	20.78	103.30
days of inventory on hand	0	1.97	-100.00
receivables turnover	1.51	0	NaN
payables turnover	2.13	4.33	-50.81
inventory turnover	0	45.73	-100.00
roe	0.14	0.14	2.62
capex per share	0.14	0.17	-20.48

• ROE:

  Debt-to-Equity Ratio:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 12.72 on 2024-06-30 Q2 from 9.56 on 2023-12-31 Q4, representing a change of 33.04%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.33 on 2024-06-30 Q2 from 1.67 on 2023-12-31 Q4, representing a change of -20.31%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 23.38 which is lower than current price 30.14, indicates the company may be overvalued.